Cyclin-Dependent Kinase Inhibitor 2A/B Homozygous Deletion Prediction and Survival Analysis
Cyclin-Dependent Kinase Inhibitor 2A/B (<i>CDKN2A/B</i>) homozygous deletion was a significant prognostic factor for gliomas and affected the treatment strategy. However, the radiomic features of <i>CDKN2A/B</i> homozygous deletion in gliomas have not been developed, and whether the radiomic feature...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2023-03-01
|
| Saila: | Brain Sciences |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2076-3425/13/4/548 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|